[go: up one dir, main page]

IS6633A - Samsetningar af fínasteríð töflum - Google Patents

Samsetningar af fínasteríð töflum

Info

Publication number
IS6633A
IS6633A IS6633A IS6633A IS6633A IS 6633 A IS6633 A IS 6633A IS 6633 A IS6633 A IS 6633A IS 6633 A IS6633 A IS 6633A IS 6633 A IS6633 A IS 6633A
Authority
IS
Iceland
Prior art keywords
compositions
finasteride
tablets
finasteride tablets
Prior art date
Application number
IS6633A
Other languages
English (en)
Inventor
Johannsson Fjalar
Irnason Birkir
Original Assignee
Omega Farma Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omega Farma Ehf. filed Critical Omega Farma Ehf.
Priority to IS6633A priority Critical patent/IS6633A/is
Priority to US10/535,826 priority patent/US20060099251A1/en
Priority to AU2003302372A priority patent/AU2003302372A1/en
Priority to EP03811862.6A priority patent/EP1575555B1/en
Priority to PCT/IS2003/000034 priority patent/WO2004047798A2/en
Publication of IS6633A publication Critical patent/IS6633A/is
Priority to IS7888A priority patent/IS2943B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS6633A 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum IS6633A (is)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum
US10/535,826 US20060099251A1 (en) 2002-11-22 2003-11-21 Formulations of finasteride
AU2003302372A AU2003302372A1 (en) 2002-11-22 2003-11-21 Formulations of finasteride
EP03811862.6A EP1575555B1 (en) 2002-11-22 2003-11-21 Formulations of finasteride
PCT/IS2003/000034 WO2004047798A2 (en) 2002-11-22 2003-11-21 Formulations of finasteride
IS7888A IS2943B (is) 2002-11-22 2005-06-10 Fínasteríðsamsetningar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum

Publications (1)

Publication Number Publication Date
IS6633A true IS6633A (is) 2004-05-23

Family

ID=36700777

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6633A IS6633A (is) 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum
IS7888A IS2943B (is) 2002-11-22 2005-06-10 Fínasteríðsamsetningar

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS7888A IS2943B (is) 2002-11-22 2005-06-10 Fínasteríðsamsetningar

Country Status (5)

Country Link
US (1) US20060099251A1 (is)
EP (1) EP1575555B1 (is)
AU (1) AU2003302372A1 (is)
IS (2) IS6633A (is)
WO (1) WO2004047798A2 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
EP3050566B1 (en) * 2007-09-10 2018-11-28 Boston Biomedical, Inc. A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
ES2987670T3 (es) 2010-03-19 2024-11-15 1Globe Biomedical Co Ltd Métodos novedosos para actuar sobre células madre cancerosas
JP5902184B2 (ja) 2010-11-22 2016-04-13 華安醫學股分有限公司Ｅｎｅｒｇｅｎｅｓｉｓ Ｂｉｏｍｅｄｉｃａｌ Ｃｏ．， Ｌｔｄ． 毛髪成長促進剤、睫毛と眉毛の成長促進剤、および脱毛防止剤
DK2465581T3 (da) 2010-12-15 2020-04-06 Energenesis Biomedical Co Ltd Ikke-terapeutisk anvendelse af en sammensætning til fremme af hårvækst
CN106211758B (zh) 2013-04-09 2021-03-23 北京强新生物科技有限公司 2-乙酰基萘并[2,3-b]呋喃-4,9-二酮用于治疗癌症的用途
EP3002005A1 (en) * 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direct compression excipient based on lactose, cellulose and starch
BR112019001225A2 (pt) * 2016-08-02 2019-04-30 Durect Corporation composições compreendendo sulfato de colesterol oxigenado e pelo menos um dentre polialquileno glicol, carboximetil celulose e polioxilglicerídeo
WO2018102427A1 (en) 2016-11-29 2018-06-07 Boston Biomedical, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
WO2018213424A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer
CN108853047A (zh) * 2018-07-25 2018-11-23 江苏黄河药业股份有限公司 一种非那雄胺片及其制备方法
CN109453134A (zh) * 2018-12-03 2019-03-12 海南赛立克药业有限公司 一种含非那雄胺的药物组合物及其制备方法
GB2610163B (en) * 2021-08-12 2023-12-13 Netriver Systems Ltd Secure online exchange of digital identification

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
GB9717428D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
GB9717444D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
WO1999021534A1 (en) * 1997-10-27 1999-05-06 Merck Patent Gmbh Solid state solutions and dispersions of poorly water soluble drugs
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents

Also Published As

Publication number Publication date
IS7888A (is) 2005-06-10
EP1575555B1 (en) 2014-08-06
AU2003302372A1 (en) 2004-06-18
WO2004047798A3 (en) 2004-07-29
US20060099251A1 (en) 2006-05-11
WO2004047798A2 (en) 2004-06-10
EP1575555A2 (en) 2005-09-21
IS2943B (is) 2016-03-15
AU2003302372A8 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
DK2206517T3 (da) Immunpotentierende sammensætninger omfattende af anti-PD-L1-antistoffer
DE60311307D1 (de) Shampoo-zusammensetzungen
DE60310912D1 (de) Waschmittelzusammensetzungen und komponenten davon
ATE351898T1 (de) Feste poröse waschmittelzusammensetzungen
DE60334997D1 (de) Waschmittelzusammensetzungen
DK1575379T3 (da) Ernæringssammensætninger
DK3395339T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
EP1575487A4 (en) MICROCRYSTALLINE CELLULOSIC COMPOSITIONS
ITMI20011062A0 (it) Composizioni fluoroelastomeriche
EP1534786A4 (en) COLORING COMPOSITIONS
DE10393374D2 (de) Zusammensetzung
DK1524981T3 (da) Sammensætninger med vedvarende frigivelse indeholdende lamotrigin
DK2402005T3 (da) Formuleringer med langvarig frigivelse af nalbuphin
DE60310914D1 (de) Pulverzusammensetzung
ITMI20011061A0 (it) Composizioni fluoroelastomeriche
IS7051A (is) Lyfjasamsetningar
DK1561472T3 (da) Faststofsammensætning
ITMI20011060A0 (it) Composizioni fluoroelastomeriche
EP1608385A4 (en) THERAPEUTIC COMPOSITIONS
NO20043937L (no) Anvendelse av vitamin D sammensetninger
DE60316954D1 (de) Shampoozusammensetzungen
IS6633A (is) Samsetningar af fínasteríð töflum
ITMI20011059A0 (it) Composizioni fluoroelastomeriche
SE0500163L (sv) Sammansättning
DK1337228T3 (da) Sammensætninger til fjernelse af human cerumen